158 related articles for article (PubMed ID: 22257962)
1. A cell-based backup to speed up pandemic influenza vaccine production.
Lee MS; Hu AY
Trends Microbiol; 2012 Mar; 20(3):103-5. PubMed ID: 22257962
[TBL] [Abstract][Full Text] [Related]
2. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.
Montomoli E; Khadang B; Piccirella S; Trombetta C; Mennitto E; Manini I; Stanzani V; Lapini G
Expert Rev Vaccines; 2012 May; 11(5):587-94. PubMed ID: 22827244
[TBL] [Abstract][Full Text] [Related]
3. Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine.
Chan CY; Tambyah PA
Expert Rev Vaccines; 2012 Jul; 11(7):759-73. PubMed ID: 22913252
[TBL] [Abstract][Full Text] [Related]
4. Continuous cell lines as a production system for influenza vaccines.
Genzel Y; Reichl U
Expert Rev Vaccines; 2009 Dec; 8(12):1681-92. PubMed ID: 19943763
[TBL] [Abstract][Full Text] [Related]
5. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
6. Development of a Vero cell-derived influenza whole virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
[TBL] [Abstract][Full Text] [Related]
7. 'Reverse genetics' could offer forward-thinking flu vaccine.
Pearson H
Nature; 2003 Dec; 426(6968):742. PubMed ID: 14685181
[No Abstract] [Full Text] [Related]
8. Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production.
Song MS; Baek YH; Pascua PNQ; Kwon HI; Park SJ; Kim EH; Lim GJ; Choi YK
J Gen Virol; 2013 Jun; 94(Pt 6):1230-1235. PubMed ID: 23486669
[TBL] [Abstract][Full Text] [Related]
9. [Safety of cell culture-based influenza vaccines].
Schmitt HJ; Gregersen JP; Trusheim H; Bröker M
Med Monatsschr Pharm; 2010 Jan; 33(1):4-10. PubMed ID: 20131669
[TBL] [Abstract][Full Text] [Related]
10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
[No Abstract] [Full Text] [Related]
11. Influenza. Synthetic vaccine strain may speed up pandemic response.
Kupferschmidt K
Science; 2013 May; 340(6134):797. PubMed ID: 23687018
[No Abstract] [Full Text] [Related]
12. [Development of a novel influenza vaccine derived from a continuous cell line].
Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation on construction and expression in vitro of nucleic acid vaccine of nucleoprotein of influenza virus A].
He JF; Fang SS; Cheng XW; Zhang R; Deng P; Zhao S
Wei Sheng Yan Jiu; 2005 Jul; 34(4):419-22. PubMed ID: 16229263
[TBL] [Abstract][Full Text] [Related]
14. Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development.
Barrett PN; Portsmouth D; Ehrlich HJ
Expert Rev Vaccines; 2013 Apr; 12(4):395-413. PubMed ID: 23560920
[TBL] [Abstract][Full Text] [Related]
15. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
Abelin A; Colegate T; Gardner S; Hehme N; Palache A
Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
[TBL] [Abstract][Full Text] [Related]
16. Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T; Kawaoka Y
Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
[TBL] [Abstract][Full Text] [Related]
17. The influence of the host cell on standardisation of influenza vaccine potency.
Wood JM; Dunleavy U; Newman RW; Riley AM; Robertson JS; Minor PD
Dev Biol Stand; 1999; 98():183-8; discussion 197. PubMed ID: 10494972
[TBL] [Abstract][Full Text] [Related]
18. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
[No Abstract] [Full Text] [Related]
19. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
20. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
